Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

2.

[Experiences of the DREAM trial].

Fövényi J.

Orv Hetil. 2006 Dec 31;147(52):2523-6. Review. Hungarian.

PMID:
17294577
3.
4.

Ramipril: a review of its use in the prevention of cardiovascular outcomes.

Warner GT, Perry CM.

Drugs. 2002;62(9):1381-405. Review.

PMID:
12076194
5.

[Progress in the prevention of type 2 diabetes].

Schernthaner G.

Wien Klin Wochenschr. 2003 Nov 28;115(21-22):745-57. Review. German.

PMID:
14743578
6.
7.

Spotlight on ramipril in the prevention of cardiovascular outcomes.

Warner GT, Perry CM.

Am J Cardiovasc Drugs. 2003;3(2):113-6. Review.

PMID:
14727938
8.

The ongoing telmisartan alone and in combination with ramipril global endpoint trial program.

Unger T.

Am J Cardiol. 2003 May 22;91(10A):28G-34G. Review.

PMID:
12781906
9.

Role of renin-angiotensin system blockade in patients with diabetes mellitus.

Braga MF, Leiter LA.

Am J Cardiol. 2009 Sep 15;104(6):835-9. doi: 10.1016/j.amjcard.2009.05.015. Review.

PMID:
19733720
10.

The HOPE Study (Heart Outcomes Prevention Evaluation).

Sleight P.

J Renin Angiotensin Aldosterone Syst. 2000 Mar;1(1):18-20. Review.

PMID:
11967789
11.

Ramipril in the treatment of vascular diseases.

Rokoss MJ, Teo KK.

Expert Opin Pharmacother. 2005 Sep;6(11):1911-9. Review.

PMID:
16144510
12.

The prevention of type 2 diabetes: what is the evidence?

Chiasson JL, Brindisi MC, Rabasa-Lhoret R.

Minerva Endocrinol. 2005 Sep;30(3):179-91. Review.

PMID:
16208307
13.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
14.

Can thiazolidinediones delay disease progression in type 2 diabetes?

Leiter LA.

Curr Med Res Opin. 2006 Jun;22(6):1193-201. Review.

PMID:
16846552
15.
16.

Cardiovascular risk and cardiometabolic protection: role of glitazones.

Petrazzi L, Grassi D, Polidoro L, D'Aurelio A, Croce G, Properzi G, Tiberti S, Desideri G, Ferri C.

J Nephrol. 2008 Nov-Dec;21(6):826-35. Review.

PMID:
19034866
17.

Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.

Wagstaff AJ, Goa KL.

Drugs. 2002;62(12):1805-37. Review.

PMID:
12149047
18.

Preventing type II diabetes mellitus.

Prisant LM.

J Clin Pharmacol. 2004 Apr;44(4):406-13. Review.

PMID:
15051749
19.

The new clinical trials with thiazolidinediones--DREAM, ADOPT, and CHICAGO: promises fulfilled?

Goldberg RB.

Curr Opin Lipidol. 2007 Aug;18(4):435-42. Review.

PMID:
17620861
20.

[Prevention of type 2 diabetes: lifestyle changes or pharmacological interventions?].

Scheen AJ, Letiexhe MR, Ernest P.

Rev Med Liege. 2003 Apr;58(4):206-10. Review. French.

Supplemental Content

Support Center